| Autophagy plays an important role in the containment of HIV-1 in nonprogressor-infected patients R Nardacci, A Amendola, F Ciccosanti, M Corazzari, V Esposito, C Vlassi, ... Autophagy 10 (7), 1167-1178, 2014 | 93 | 2014 |
| Infection‐related and‐unrelated malignancies, HIV and the aging population L Shepherd, ÁH Borges, B Ledergerber, P Domingo, A Castagna, ... HIV medicine 17 (8), 590-600, 2016 | 91 | 2016 |
| Liver sinusoidal endothelial cells (LSECs) modifications in patients with chronic hepatitis C A Baiocchini, F Del Nonno, C Taibi, U Visco-Comandini, G D’Offizi, ... Scientific reports 9 (1), 8760, 2019 | 59 | 2019 |
| Role of testosterone in SARS-CoV-2 infection: A key pathogenic factor and a biomarker for severe pneumonia M Camici, P Zuppi, P Lorenzini, L Scarnecchia, C Pinnetti, S Cicalini, ... International Journal of Infectious Diseases 108, 244-251, 2021 | 43 | 2021 |
| Survival after the diagnosis of de novo malignancy in liver transplant recipients M Taborelli, P Piselli, GM Ettorre, U Baccarani, P Burra, A Lauro, ... International Journal of Cancer 144 (2), 232-239, 2019 | 33 | 2019 |
| Risk of virus and non‐virus related malignancies following immunosuppression in a cohort of liver transplant recipients. Italy, 1985–2014 M Taborelli, P Piselli, GM Ettorre, A Lauro, L Galatioto, U Baccarani, ... International journal of cancer 143 (7), 1588-1594, 2018 | 31 | 2018 |
| Risk and predictive factors of prolonged viral RNA shedding in upper respiratory specimens in a large cohort of COVID-19 patients admitted to an Italian reference hospital A Mondi, P Lorenzini, C Castilletti, R Gagliardini, E Lalle, A Corpolongo, ... International Journal of Infectious Diseases 105, 532-539, 2021 | 25 | 2021 |
| No impact of interleukin-28B polymorphisms on spontaneous or drug-induced hepatitis delta virus clearance U Visco-Comandini, D Lapa, C Taibi, C Angeletti, MR Capobianchi, ... Digestive and Liver Disease 46 (4), 348-352, 2014 | 25 | 2014 |
| IFNL4 and IFNL3 associated polymorphisms strongly influence the spontaneous IFN-alpha receptor-1 expression in HCV-infected patients L Bordi, C Caglioti, AR Garbuglia, D Lapa, C Castilletti, C Taibi, ... PLoS One 10 (2), e0117397, 2015 | 20 | 2015 |
| Lack of reduction in serum alpha‐fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with … C Masetti, R Lionetti, M Lupo, M Siciliano, V Giannelli, FR Ponziani, E Teti, ... Journal of viral hepatitis 25 (12), 1493-1500, 2018 | 16 | 2018 |
| Characterization of naturally occurring NS5A and NS5B polymorphisms in patients infected with HCV genotype 3a treated with direct-acting antiviral agents B Bartolini, E Giombini, C Taibi, R Lionetti, M Montalbano, ... Viruses 9 (8), 212, 2017 | 15 | 2017 |
| IFN-Alpha receptor-1 upregulation in PBMC from HCV naive patients carrying cc genotype. possible role of IFN-lambda E Lalle, L Bordi, C Caglioti, AR Garbuglia, C Castilletti, C Taibi, ... PloS one 9 (4), e93434, 2014 | 15 | 2014 |
| Daclatasvir, sofosbuvir with or without ribavirin for 24 weeks in hepatitis C genotype 3 cirrhosis: A real-life study R Lionetti, P Piccolo, I Lenci, M Siciliano, U Visco-Comandini, A De Santis, ... Annals of hepatology 18 (3), 434-438, 2019 | 13 | 2019 |
| Dynamics of HCV genotype 4 resistance-associated variants during virologic escape with pIFN/RBV+ daclatasvir: A case study using ultra deep pyrosequencing B Bartolini, R Lionetti, E Giombini, C Sias, C Taibi, M Montalbano, ... Journal of Clinical Virology 66, 38-43, 2015 | 13 | 2015 |
| Acute hepatitis associated with clopidogrel: a case report and review of the literature R Pisapia, A Abdeddaim, A Mariano, A Rianda, L Vincenzi, C Taibi, ... American Journal of Therapeutics 22 (1), e8-e13, 2015 | 12 | 2015 |
| The clinical significance of HCV core antigen detection during Telaprevir/Peg-Interferon/Ribavirin therapy in patients with HCV 1 genotype infection AR Garbuglia, R Lionetti, D Lapa, C Taibi, U Visco-Comandini, ... Journal of Clinical Virology 69, 68-73, 2015 | 11 | 2015 |
| Late relapse and reinfection in HCV patients treated with direct-acting antiviral (DAA) drugs C Minosse, CEM Gruber, M Rueca, C Taibi, M Zaccarelli, E Grilli, ... Viruses 13 (6), 1151, 2021 | 10 | 2021 |
| High levels of TRIM5α are associated with xenophagy in HIV-1-infected long-term nonprogressors F Ciccosanti, M Corazzari, R Casetti, A Amendola, D Collalto, G Refolo, ... Cells 10 (5), 1207, 2021 | 10 | 2021 |
| HCV NS3 quasispecies in liver and plasma and dynamics of telaprevir-resistant variants in breakthrough patients assessed by UDPS: A case study B Bartolini, M Selleri, AR Garbuglia, E Giombini, C Taibi, R Lionetti, ... Journal of Clinical Virology 72, 60-65, 2015 | 10 | 2015 |
| Clinical and virological properties of hepatitis C virus genotype 4 infection in patients treated with different direct-acting antiviral agents C Minosse, M Selleri, E Giombini, B Bartolini, MR Capobianchi, S Cerilli, ... Infection and Drug Resistance, 2117-2127, 2018 | 9 | 2018 |
